Productivity augmenting protein factor, novel cell lines and uses thereof

Details for Australian Patent Application No. 2006310999 (hide)

Owner ProBioGen AG

Inventors Jordan, Ingo; Brundke, Elisabeth; Sandig, Volker

Agent Davies Collison Cave

Pub. Number AU-B-2006310999

PCT Pub. Number WO2007/054516

Priority 60/750,156 14.12.05 US; 05110453.7 08.11.05 EP

Filing date 8 November 2006

Wipo publication date 18 May 2007

Acceptance publication date 12 April 2012

International Classifications

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C07K 14/01 (2006.01) Peptides having more than 20 amino acids

C07K 14/075 (2006.01) Peptides having more than 20 amino acids

C12N 5/16 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/054516 Priority application(s): WO2007/054516

11 September 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Jordan, Ingo; Brundke, Elisabeth and Sandig, Volker

12 April 2012 Application Accepted

  Published as AU-B-2006310999

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006311003-Methods for the identification of microRNA and their applications in research and human health

2006310997-Use of PDE III inhibitors or calcium sensitizers for the treatment of asymptomatic (occult) heart failure